Pharmaceutical Grade GS 441524 FIP Cat GS-441 Injection Liquid

Basic Properties
Model Number: GS-441524
Trading Properties
Minimum Order Quantity: 10 vials
Price: Negotiable
Payment Terms: L/C,D/A,D/P,T/T,Western Union
Supply Ability: 100000 vials per month
Specifications
Grade: Pharmaceutcial Grade Function: Cat FIPV
CAS: 1191237-69-0 Purity: 20mg/mL
Shelf Life: 2 Years Test Method: HPLC UV
Storage: Cool Dry Place Sample: Available
Shipping Method: Air(UPS, FedEx, TNT, EMS) Or Sea MF: C12H13N5O4
Highlight: Pharmaceutical Grade Gs 44152 Fip, Gs 44152 Fip Cat, Cat GS-441 Injection
Product Description

Gallery

Pharmaceutical Grade GS 441524 FIP Cat GS-441 Injection Liquid

Pharmaceutical Grade GS 441524 FIP Cat GS-441 Injection Liquid 0

Pharmaceutical Grade GS 441524 FIP Cat GS-441 Injection Liquid 1


GS-441 Supplier Cat FIP Injection With Fast Delivery

Product Description

This medicine is an adenosine nucleotide analog antiviral, similar to remdesivi.This molecule was patented in 2009. In vitro studies of GS have determined it has a higher EC50 than remdesivi against a number of viruses, meaning GS is less potent.This medicine continues to be studied in the treatment of Feline Infectious Peritonitis Virus, that only infects cats.

Appearance Transparent liquid, powder or tablets
GS Standard 99.5%min
Size 5.5 ml/ Vial
Content 15mg/ml or 20mg/ml
Application For CAT FIP R&D Use ONLY
Wet FIP 6-7 mg/kg
Dry FIP 7-8 mg/kg
Ocular or Neuro FIP 8 mg/kg
Increased ocular/neuro 9 mg/kg
Max ocular/neuro 10 mg/kg


How GS441524 Cures FIP?
If a cat's immune system is healthy and mature, the white blood cells should fight off an infection or virus, and allow the cat to build up an immune response, or antibodies. Cats who develop FIP have an immune defect or deficiency that causes the white blood cells to replicate, rather than fight, the virus. Essentially, the cats immune system is spreading the virus throughout the cat's body rather than trying to eliminate it. Cats who have no immune response develop wet FIP, while cats who have a partial immune response develop dry FIP.

The nucleoside analog GS is a molecular precursor to a pharmacologically active nucleoside triphosphate molecule. These analogs act as an alternative substrate and RNA-chain terminator of viral RNA dependent RNA polymerase. In layman's terms, GS interjects itself into the chain reaction and stops the replication of the virus.